Milae Bioresources Co. Ltd (218150) - Total Liabilities

Latest as of December 2025: ₩16.21 Billion KRW ≈ $10.99 Million USD

Based on the latest financial reports, Milae Bioresources Co. Ltd (218150) has total liabilities worth ₩16.21 Billion KRW (≈ $10.99 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 218150 operating cash flow to assess how effectively this company generates cash.

Milae Bioresources Co. Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Milae Bioresources Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 218150 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Milae Bioresources Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Milae Bioresources Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
NDL Ventures Limited
NSE:NDLVENTURE
India Rs60.70 Million
Lotte Chilsung Beverage Co Ltd
KO:005305
Korea ₩2.81 Trillion
Corby Spirit and Wine Limited
TO:CSW-B
Canada CA$205.10 Million
Findi Ltd
AU:FND
Australia AU$257.71 Million
JSS Real Estate SOCIMI SA
MC:YJSS
Spain €291.53 Million
Yuyu Pharma Inc
KO:000227
Korea ₩63.32 Billion
OS Therapies Incorporated
NYSE MKT:OSTX
USA $4.25 Million
Birko Birlesik Koyunlulular Mensucat Ticaret ve Sanayi AS
IS:BRKO
Turkey TL76.78 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Milae Bioresources Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 218150 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.11 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.40 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.27 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Milae Bioresources Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Milae Bioresources Co. Ltd (2016–2025)

The table below shows the annual total liabilities of Milae Bioresources Co. Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 ₩16.21 Billion
≈ $10.99 Million
-20.24%
2024-12-31 ₩20.32 Billion
≈ $13.77 Million
+173.52%
2023-12-31 ₩7.43 Billion
≈ $5.04 Million
-51.59%
2022-12-31 ₩15.35 Billion
≈ $10.40 Million
-31.79%
2021-12-31 ₩22.50 Billion
≈ $15.25 Million
+161.23%
2020-12-31 ₩8.61 Billion
≈ $5.84 Million
-2.74%
2019-12-31 ₩8.86 Billion
≈ $6.00 Million
+56.43%
2018-12-31 ₩5.66 Billion
≈ $3.84 Million
-10.07%
2017-12-31 ₩6.30 Billion
≈ $4.27 Million
+310.87%
2016-12-31 ₩1.53 Billion
≈ $1.04 Million
--

About Milae Bioresources Co. Ltd

KQ:218150 Korea Farm Products
Market Cap
$43.00 Million
₩63.46 Billion KRW
Market Cap Rank
#22421 Global
#1516 in Korea
Share Price
₩3255.00
Change (1 day)
-0.91%
52-Week Range
₩2880.00 - ₩4120.00
All Time High
₩11750.00
About

Milae Bioresources Co., Ltd. provides feed additives in Korea. It also offers processed feed, feed preservatives, and feed ingredients. In addition, the company offers minerals and other specialty feed additives. The company was founded in 1998 and is based in Seoul, South Korea.